References
- 1. M. A. Avachat, K. B. Patel, M. S. Rokade and R. R. Dash, Formulation and characterization of an expandable, gastroretentive system of carvedilol phosphate by 32 factorial design, PDA J. Pharm. Sci. Technol. 65 (2011) 12-19; DOI: 10.4103/2230-973X.85964.10.4103/2230-973X.85964346514023071937
- 2. S. Albers, B. Meibohm, T. S. Mir and S. Laer, Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure, Br. J. Clin. Pharmacol. 65 (2008) 511-522; DOI: 10.1111/j.1365-2125.2007.03046.x.10.1111/j.1365-2125.2007.03046.x229138017995971
- 3. W. Wu, Q. Zhou, H. B. Zhang, G. D. Ma and C. D. Fu, Studies on nimodipine sustained release tablet capable of floating on gastric fluids with prolonged gastric resident time, Yao Xue Bao. 32 (1997) 786-790; DOI: 10.1016/j.ejpb.2010.09.017.10.1016/j.ejpb.2010.09.01720934511
- 4. C. Shilpa, B. Manish and S. Ajinath, Formulation and evaluation of bilayer floating tablet of carvedilol phosphate, J. Drug Del. Ther. 2 (2012) 9-19.
- 5. D. S. Goswami and M. Seth, Formulation and evaluation of pioglitazone floating tablet, Int. J. Res. Pharm. Biomed. Sci. 4 (2013) 628-632.
- 6. A. J. Rajamma, H. N. Yogesha and S. B. Sateesha, Natural gums as sustained release carriers: development of gastraretentive drug delivery system of ziprasidone HCl, DARU J. Pharm. Sci. 20 (2012) 58; DOI: 10.1186/2008-2231-20-58.10.1186/2008-2231-20-58355600723352292
- 7. M. V. Srikanth, S. A. Sunil, N. S. Rao, B. J. Ram and K. V. R. Murthy, Statistical design and evaluation of a propranolol HCl gastric floating tablet, Acta Pharm. Sinica B 2 (2012) 60-69; DOI: http://dx.doi.org/10.1016/j.apsb.2011.12.008.10.1016/j.apsb.2011.12.008
- 8. A. Sharma, C. Prakash Jain and Y. Singh Tanwar, Preparation and characterization of solid dispersions of carvedilol with poloxamer 188, J. Chil. Chem. Soc. 58 (2013) 1553-1557; DOI: 10.4067/S0717-97072013000100012.10.4067/S0717-97072013000100012
- 9. A. Sharma and C. P. Jain, Preparation and characterization of solid dispersions of carvedilol with PVP K30, Res. Pharm. Sci. 5 (2010) 49-56.
- 10. USP 2011, Revision bulletin, The United States Pharmacopeial Convention, Rockville (MD), PA: National Publishing; January 1, 2011; pp. 1-3. 11 A. Abdelbary, O. N. El-Gazayerly, N. A. El-Gendy and A. A. Ali, Floating tablet of trimetazidine dihydrochloride: an approach for extended release with zero-order kinetics, AAPS PharmSciTech. 11 (2010) 1058-1067; DOI: 10.1208/s12249-010-9468-y.10.1208/s12249-010-9468-y297411520582493
- 12. M. V. Srikanth, S. A. Sunil, N. S. Rao, V. Raju and K. V. R. Murthy, Investigation on in vitro dissolution rate enhancement of indomethacin by using a novel carrier sucrose fatty acid ester, DARU J. Pharm. Sci. 20 (2012) 1-10; DOI: 10.1186/1560-8115-20-4.10.1186/1560-8115-20-4351453923226721
- 13. P. T. Koh, J. N. Chuah and S. Garg, Formulation development and dissolution rate enhancement of efavirenz by solid dispersion systems, Indian J. Pharm. Sci. 75 (2013) 291-301; DOI: 10.4103/0250-474X.117434.10.4103/0250-474X.117434378374724082345
- 14. K. G. Ravikumar, O. G. Vinaya and U. Santhikrishna, Development of floating matrix tablets of salbutamol sulphate and study of drug release kinetics, Int. J. Res. Pharm. Biomed. Sci. 3 (2012) 1346-1354.
- 15. R. Arza, C. S. Rao Gonugunta and V. P. Reddy, Formulation and evaluation of swellable and floating gastroretentive ciprofloxacin hydrochloride tablets, AAPS PharmSciTech. 10 (2009) 220-226; DOI: 10.1208/s12249-009-9200-y.10.1208/s12249-009-9200-y266369019277869
- 16. C. Ramesh, N. Nagarwal, N. Devendra, J. Ridhurkar and K. Pandit, In vitro release kinetics and bioavailability of gastroretentive cinnarizine hydrochloride tablet, AAPS PharmSciTech. 11 (2010) 294-303; DOI: 10.1208/s12249-010-9380-5. 10.1208/s12249-010-9380-5285045520182827